GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT

Organization

  • BRENTFORD, GB

Patents Grantslast 30 patents

  • Information Patent Grant

    Heterocyclic amides useful as protein modulators

    • Patent number 11,970,480
    • Issue date Apr 30, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Adam Kenneth Charnley
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds

    • Patent number 11,969,423
    • Issue date Apr 30, 2024
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    • Esther Porras De Francisco
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Hydroxypyridoxazepines as NRF2 activators

    • Patent number 11,945,826
    • Issue date Apr 2, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Mark Elban
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds useful in HIV therapy

    • Patent number 11,873,310
    • Issue date Jan 16, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Vincent Wing-Fai Tai
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    IL-7 binding proteins and their use in medical therapy

    • Patent number 11,802,150
    • Issue date Oct 31, 2023
    • GlaxoSmith Kline Intellectual Property Development Limited
    • Gerben Bouma
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Stable cell lines for retroviral production

    • Patent number 11,795,474
    • Issue date Oct 24, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Conrad Vink
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    Substituted pyridines as DNMT1 inhibitors

    • Patent number 11,771,711
    • Issue date Oct 3, 2023
    • GlaxoSmith Kline Intellectual Property Development Limited
    • Andrew B. Benowitz
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Furin inhibitors

    • Patent number 11,773,078
    • Issue date Oct 3, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jeffrey Michael Axten
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    C-mannoside compounds useful for the treatment of urinary tract inf...

    • Patent number 11,697,665
    • Issue date Jul 11, 2023
    • Fimbrion Therapeutics, Inc.
    • Michael Joseph Bishop
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Anti-ICOS and anti-PD-1 antibody combination therapy

    • Patent number 11,649,289
    • Issue date May 16, 2023
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    • Sabyasachi Bhattacharya
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Substituted pyrazolo[1,5-a]pyrimidines as PI4K inhibitors

    • Patent number 11,649,238
    • Issue date May 16, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Nicholas Paul Barton
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Indanes as NRF2 activators

    • Patent number 11,643,407
    • Issue date May 9, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jeffrey K. Kerns
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Biopharmaceutical compositions comprising antibody variants

    • Patent number 11,613,571
    • Issue date Mar 28, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Chika Akinseye
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Treatment of inflammatory disorders

    • Patent number 11,577,082
    • Issue date Feb 14, 2023
    • Galvani Bioelectronics Limited
    • Philippe Blancou
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Antibody variants

    • Patent number 11,566,347
    • Issue date Jan 31, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Valeriu Damian
    • C40 - COMBINATORIAL CHEMISTRY
  • Information Patent Grant

    Oxepinopyrazole derivatives as inhibitors of P13-kinase activity

    • Patent number 11,555,040
    • Issue date Jan 17, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Andrew Baxter
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Chemical compounds

    • Patent number 11,547,704
    • Issue date Jan 10, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jeffrey Michael Axten
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Carboxyesterase biocatalysts

    • Patent number 11,535,833
    • Issue date Dec 27, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Kristin K. Brown
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    Methods for purifying antibodies

    • Patent number 11,530,238
    • Issue date Dec 20, 2022
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    • Andre C. Dumetz
    • B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • Information Patent Grant

    Compounds useful in HIV therapy

    • Patent number 11,492,361
    • Issue date Nov 8, 2022
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    • Richard M. Dunham
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Heterocyclic amides as kinase inhibitors

    • Patent number 11,485,710
    • Issue date Nov 1, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Antigen binding proteins

    • Patent number 11,479,607
    • Issue date Oct 25, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Yan Y. Degenhardt
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds for the treatment of parasitic infections

    • Patent number 11,453,657
    • Issue date Sep 27, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Maria Isabel Castellote Alvaro
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Modular aseptic production system

    • Patent number 11,434,032
    • Issue date Sep 6, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Francesco Sanmartin
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Targeted protein degradation

    • Patent number 11,427,643
    • Issue date Aug 30, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Lewis Lee Brayshaw
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Combination treatment for cancer with anti-BCMA binding protein and...

    • Patent number 11,401,334
    • Issue date Aug 2, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Sanjay Khandekar
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Modulators of stimulator of interferon genes (STING)

    • Patent number 11,377,440
    • Issue date Jul 5, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • David T. Fosbenner
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Heterocyclic amides useful as protein modulators

    • Patent number 11,365,190
    • Issue date Jun 21, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Adam Kenneth Charnley
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Prognostic method

    • Patent number 11,353,458
    • Issue date Jun 7, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Danton Bounds
    • G01 - MEASURING TESTING
  • Information Patent Grant

    Ghrelin O-acyltransferase inhibitors

    • Patent number 11,312,709
    • Issue date Apr 26, 2022
    • GlaxoSmithKline Intellectual Property Development Limited
    • Anish Bandyopadhyay
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

  • Information Patent Application

    Treatment Regimen

    • Publication number 20240108620
    • Publication date Apr 4, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Nicole SCANGARELLA-OMAN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    Nitrogen Containing 2,3-Dihydroquinazolinone Compounds as Nav1.8 In...

    • Publication number 20240083896
    • Publication date Mar 14, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Xiaoyang DONG
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CATHEPSIN INHIBITORS FOR PREVENTING OR TREATING VIRAL INFECTIONS

    • Publication number 20240066037
    • Publication date Feb 29, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Sina BAVARI
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    Compounds Useful in HIV Therapy

    • Publication number 20240051972
    • Publication date Feb 15, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Martha DE LA ROSA
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    INTERLEUKIN 5 BINDING PROTEIN DOSAGE REGIMEN

    • Publication number 20240043524
    • Publication date Feb 8, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Daren J AUSTIN
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    IL-7 Binding Proteins and Their Use in Medical Therapy

    • Publication number 20240025988
    • Publication date Jan 25, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Gerben BOUMA
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    Chemical Compounds

    • Publication number 20230416287
    • Publication date Dec 28, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jie GUANG
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    IMIDAZONAPHTHYRIDINES AND IMIDAZOPYRIDOPYRIMIDINES AS IFNAR2 AGONIS...

    • Publication number 20230322779
    • Publication date Oct 12, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jorge Esparza GORDILLO
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    ANTIGEN BINDING PROTEINS

    • Publication number 20230295295
    • Publication date Sep 21, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Paul Andrew HAMBLIN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    IL1RAP BINDING PROTEINS

    • Publication number 20230295313
    • Publication date Sep 21, 2023
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    • John G. Emery
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    C-MANNOSIDE COMPOUNDS USEFUL FOR THE TREATMENT OF URINARY TRACT INF...

    • Publication number 20230287028
    • Publication date Sep 14, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Michael Joseph BISHOP
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    Antigen Binding Proteins

    • Publication number 20230279106
    • Publication date Sep 7, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Yan Y. DEGENHARDT
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    ANTIGEN BINDING PROTEIN

    • Publication number 20230279089
    • Publication date Sep 7, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jane Elizabeth CLARKSON
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    ANTIGEN BINDING PROTEINS

    • Publication number 20230242642
    • Publication date Aug 3, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Paul Andrew HAMBLIN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    Heterocyclic Amides as Kinase Inhibitors

    • Publication number 20230192676
    • Publication date Jun 22, 2023
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    • Ryan Michael Fox
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CARBOXYESTERASE BIOCATALYSTS

    • Publication number 20230193227
    • Publication date Jun 22, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Kristin K. Brown
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    CHIMERIC ANTIGEN RECEPTORS TARGETING CLAUDIN-3 AND METHODS FOR TREA...

    • Publication number 20230192842
    • Publication date Jun 22, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Thomas Southgate
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    METHOD FOR DETECTING POLYSORBATES

    • Publication number 20230184750
    • Publication date Jun 15, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Katie A. CARNES
    • G01 - MEASURING TESTING
  • Information Patent Application

    CRYSTALLINE FORMS OF GEPOTIDACIN

    • Publication number 20230167113
    • Publication date Jun 1, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Ricky Wayne COUCH
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CHEMICAL COMPOUNDS

    • Publication number 20230165848
    • Publication date Jun 1, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Jeffrey Michael AXTEN
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    COMBINATION TREATMENT FOR CANCER BASED UPON AN ICOS ANTBODY AND A P...

    • Publication number 20230149543
    • Publication date May 18, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Marc S. BALLAS
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    MODIFIED VECTORS FOR PRODUCTION OF RETROVIRUS

    • Publication number 20230151388
    • Publication date May 18, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Nathan SWEENEY
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    COMBINATION TREATMENT FOR CANCER

    • Publication number 20230131598
    • Publication date Apr 27, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Marc S. BALLAS
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    HETEROCYCLIC AMIDES AS KINASE INHIBITORS

    • Publication number 20230120185
    • Publication date Apr 20, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Niall Andrew Anderson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PI4KIIIBETA INHIBITORS

    • Publication number 20230124394
    • Publication date Apr 20, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Nicholas Paul BARTON
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    2,3-DIHYDROQUINAZOLIN COMPOUNDS AS NAV1.8 INHIBITORS

    • Publication number 20230103791
    • Publication date Apr 6, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Roderick S. DAVIS
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    COMBINATION THERAPY

    • Publication number 20230094076
    • Publication date Mar 30, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Olena I. BARBASH
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    SUBSTITUTED PYRIDINES AS DNMT1 INHIBITORS

    • Publication number 20230101987
    • Publication date Mar 30, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Andrew B. BENOWITZ
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    Heterocyclic Amides Useful as Protein Modulators

    • Publication number 20230071675
    • Publication date Mar 9, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Adam Kenneth CHARNLEY
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Combination Treatments and Uses and Methods Thereof

    • Publication number 20230067202
    • Publication date Mar 2, 2023
    • GlaxoSmithKline Intellectual Property Development Limited
    • Ira GUPTA
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE